Morocco Authorizes New Cannabis-Based Medicines for Epilepsy

What Are the New Cannabis Medicines for Epilepsy?

The newly approved cannabis-based medications aim to offer alternative treatment options for individuals suffering from epilepsy. Despite this exciting advancement, specific details regarding the names, prices, and formulations of these medications have not yet been disclosed by Sothema. It remains uncertain whether these drugs will be covered by health insurance plans.

Why is Morocco’s Cannabis Market Important?

Morocco is historically known as the largest producer and exporter of hashish on the black market. However, the landscape of cannabis production in Morocco is changing. With increased competition from European-grown cannabis flowers, Moroccan producers are enhancing their cultivation practices and refining hashish manufacturing techniques to deliver higher-quality products.

How Did Morocco Legalize Medical Cannabis?

In 2021, Morocco took a significant step by legalizing cannabis for medical and industrial use. The National Agency for the Regulation of Cannabis-Related Activities (ANRAC) is now responsible for overseeing this burgeoning sector, granting licenses to both cultivators and processors.

Who is Sothema?

Sothema, the pharmaceutical laboratory behind these new epilepsy medications, is listed on the Casablanca Stock Exchange and is a pioneer in Morocco's pharmaceutical industry. Founded in 1976 by Omar Tazi, and currently led by his daughter, Lamia Tazi, Sothema was among the first Moroccan laboratories to venture into the legalized cannabis market. Lamia Tazi is a qualified pharmacist and studied at the University of Liège in Belgium.

What Ongoing Research is Sothema Involved In?

In July 2025, Sothema entered a groundbreaking agreement with the Mohammed VI Center for Research and Innovation. This partnership aims to establish a research center focused on cannabinoids in Bouskoura, near Casablanca. Additionally, Sothema is collaborating with the Tangier University Hospital Center (CHU) on clinical studies aimed at addressing drug-resistant epilepsy in children. Their research efforts are also extending to other conditions such as multiple sclerosis and chronic pain.

The Future of Cannabis-Based Treatments in Morocco

As the Moroccan cannabis market continues to evolve, the introduction of these new cannabis-based epilepsy medications signifies a promising shift toward integrating medical cannabis into treatment regimens. Keep an eye out for more updates on the specific details surrounding these medications, as they could transform the treatment landscape for epilepsy in Morocco.

For more information on medical cannabis development in Morocco, stay tuned for future updates and insights.

Morocco has recently taken a significant step in the realm of medical cannabis by authorizing three new cannabis-based medicines specifically designed for the treatment of epilepsy. This groundbreaking development comes from the Moroccan pharmaceutical company Sothema, in collaboration with the Mohammed VI Foundation for Science and Health.

What Are the New Cannabis Medicines for Epilepsy?

The newly approved cannabis-based medications aim to offer alternative treatment options for individuals suffering from epilepsy. Despite this exciting advancement, specific details regarding the names, prices, and formulations of these medications have not yet been disclosed by Sothema. It remains uncertain whether these drugs will be covered by health insurance plans.

Why is Morocco’s Cannabis Market Important?

Morocco is historically known as the largest producer and exporter of hashish on the black market. However, the landscape of cannabis production in Morocco is changing. With increased competition from European-grown cannabis flowers, Moroccan producers are enhancing their cultivation practices and refining hashish manufacturing techniques to deliver higher-quality products.

How Did Morocco Legalize Medical Cannabis?

In 2021, Morocco took a significant step by legalizing cannabis for medical and industrial use. The National Agency for the Regulation of Cannabis-Related Activities (ANRAC) is now responsible for overseeing this burgeoning sector, granting licenses to both cultivators and processors.

Who is Sothema?

Sothema, the pharmaceutical laboratory behind these new epilepsy medications, is listed on the Casablanca Stock Exchange and is a pioneer in Morocco's pharmaceutical industry. Founded in 1976 by Omar Tazi, and currently led by his daughter, Lamia Tazi, Sothema was among the first Moroccan laboratories to venture into the legalized cannabis market. Lamia Tazi is a qualified pharmacist and studied at the University of Liège in Belgium.

What Ongoing Research is Sothema Involved In?

In July 2025, Sothema entered a groundbreaking agreement with the Mohammed VI Center for Research and Innovation. This partnership aims to establish a research center focused on cannabinoids in Bouskoura, near Casablanca. Additionally, Sothema is collaborating with the Tangier University Hospital Center (CHU) on clinical studies aimed at addressing drug-resistant epilepsy in children. Their research efforts are also extending to other conditions such as multiple sclerosis and chronic pain.

The Future of Cannabis-Based Treatments in Morocco

As the Moroccan cannabis market continues to evolve, the introduction of these new cannabis-based epilepsy medications signifies a promising shift toward integrating medical cannabis into treatment regimens. Keep an eye out for more updates on the specific details surrounding these medications, as they could transform the treatment landscape for epilepsy in Morocco.

For more information on medical cannabis development in Morocco, stay tuned for future updates and insights.

More From Soft Secrets:

Hexocannabitriol: A Promising Cannabinoid with Antibacterial Properties

Understanding Cannabis Allergies: Symptoms, Causes, and Treatments